PhRMA Again Appeals Medicare Drug Price Fight to Fifth Circuit

The drug industry’s top lobbying group is appealing its latest loss in its challenge to Medicare’s Drug Price Negotiation Program to the Fifth Circuit, returning the case to an appeals court that has appeared sympathetic to the group’s challenge.

The Pharmaceutical Research and Manufacturers of America, along with co-plaintiffs the National Infusion Center Association and the Global Colon Cancer Association, filed a notice of appeal that it will again go to the US Court of Appeals for the Fifth Circuit. Wednesday’s move follows a lower court opinion in early August that ruled against the health groups’ claims that the program ...